Matvey Brokhin

Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System

R. Michael Tuttle, Hernán Tala, Jatin P. Shah et al. · Thyroid · 2010 · 933 citations · Full text

Medicine, Oncology, Surgery +16

Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal

R. Michael Tuttle, Matvey Brokhin, Gal Omry et al. · Journal of Nuclear Medicine · 2008 · 142 citations · Full text

Medicine, Endocrinology, Surgery +17

Even Without Additional Therapy, Serum Thyroglobulin Concentrations Often Decline for Years After Total Thyroidectomy and Radioactive Remnant Ablation in Patients with Differentiated Thyroid Cancer

Rosália do Prado Padovani, Eyal Robenshtok, Matvey Brokhin et al. · Thyroid · 2012 · 93 citations

Medicine, Oncology, Endocrine Surgery +16

Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function

R. Michael Tuttle, Norma López, Rébecca Leboeuf et al. · Thyroid · 2010 · 65 citations

Medicine, Endocrinology, Nuclear Medicine +17

Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing‐related increases in body mass in thyroid cancer survivors

Hanah Polotsky, Matvey Brokhin, Gal Omry et al. · Clinical Endocrinology · 2011 · 33 citations

Medicine, Endocrinology, Surgery +16